Eicosanoid-dependent cancer cachexia and wasting

James A Ross, Kenneth C H Fearon

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

The reversal of catabolic processes remains a significant challenge related, in part, to their complexity and our incomplete understanding of the mechanisms involved. The eicosanoids are key players in the inflammatory process and have been implicated in the process of cancer cachexia. They are unsaturated C20 fatty acids which can be separated into two main groups: the lipoxygenase products including leukotrienes and lipoxins, and the prostanoids including prostaglandins, prostacyclin and thromboxane. This review examines the biology of the eicosanoids and the evidence of a role for the eicosanoids in cancer cachexia and wasting.
Original languageEnglish
Pages (from-to)241-8
Number of pages8
JournalCurrent Opinion in Clinical Nutrition and Metabolic Care
Issue number3
Publication statusPublished - 2002


Dive into the research topics of 'Eicosanoid-dependent cancer cachexia and wasting'. Together they form a unique fingerprint.

Cite this